ABVC Biopharma Inc (ABVC) has fallen Wednesday morning, with the stock decreasing -4.63% in pre-market trading to 1.03. ABVC's short-term technical score of 54 indicates that the stock has traded more bullishly over the last month than 54% of stocks on the market. In the Biotechnology industry, which ranks 132 out of 146 industries, ABVC ranks higher than 71% of stocks. ABVC Biopharma Inc has risen 3.85% over the past month, closing at $0.87 on October 4. During this period of time, the stock fell as low as $0.81 and as high as $3.35. ABVC has an average analyst recommendation of Sell. The company has an average price target of $20.20.
ABVC has an Overall Score of 74. Find out what this means to you and get the rest of the rankings on ABVC!